TY - JOUR
T1 - Remarkably enhanced inhibitory effects of three-component hybrid liposomes including sugar surfactants on the growth of lung carcinoma cells
AU - Ueoka, Ryuichi
AU - Matsumoto, Yoko
AU - Hirose, Shigeru
AU - Goto, Koichi
AU - Goto, Masahiro
AU - Furusaki, Shintaro
PY - 2002/4/1
Y1 - 2002/4/1
N2 - Sugar parts play important roles in recognizing molecules on the cell membranes. We successfully produced sugar-type micellar surfactants, lactonoalkylamide (LacCn), for the first time. Spherical vesicles, three-component hybrid liposomes, were obtained after the sonication of the mixture of L-α-dimyristoylphosphatidylcholine (DMPC), Tween 20 and LacCn (DMPC: Tween 20:LacCn=65:7:28). It is noteworthy that high inhibitory effects of the three-component hybrid liposomes composed of DMPC, Tween 20, and LacCn (DMPC: Tween 20:LacCn=65:7:28) on the growth of glioma (U251) and lung adenocarcinoma (RERF-LC-OK) cells were attained in vitro without any drug, although no significant inhibitory effects of any individual component (DMPC, Tween 20, LacCn) or the two-component hybrid liposomes of DMPC and Tween 20 on the growth of tumor cells examined were obtained.
AB - Sugar parts play important roles in recognizing molecules on the cell membranes. We successfully produced sugar-type micellar surfactants, lactonoalkylamide (LacCn), for the first time. Spherical vesicles, three-component hybrid liposomes, were obtained after the sonication of the mixture of L-α-dimyristoylphosphatidylcholine (DMPC), Tween 20 and LacCn (DMPC: Tween 20:LacCn=65:7:28). It is noteworthy that high inhibitory effects of the three-component hybrid liposomes composed of DMPC, Tween 20, and LacCn (DMPC: Tween 20:LacCn=65:7:28) on the growth of glioma (U251) and lung adenocarcinoma (RERF-LC-OK) cells were attained in vitro without any drug, although no significant inhibitory effects of any individual component (DMPC, Tween 20, LacCn) or the two-component hybrid liposomes of DMPC and Tween 20 on the growth of tumor cells examined were obtained.
UR - http://www.scopus.com/inward/record.url?scp=0036549711&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036549711&partnerID=8YFLogxK
U2 - 10.1248/cpb.50.563
DO - 10.1248/cpb.50.563
M3 - Article
C2 - 11964013
AN - SCOPUS:0036549711
SN - 0009-2363
VL - 50
SP - 563
EP - 565
JO - Chemical and Pharmaceutical Bulletin
JF - Chemical and Pharmaceutical Bulletin
IS - 4
ER -